Printer Friendly
The Free Library
14,634,800 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Teva Receives FDA Approval of Etodolac 400mg Tablets.


JERUSALEM--(BUSINESS WIRE)--Nov. 26, 1997--Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVIY) today announced that it has received approval from the Food and Drug Administration (FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
) to manufacture and market Etodolac etodolac /eto·do·lac/ (e-to-do´lak) a nonsteroidal antiinflammatory drug used as an analgesic and antiinflammatory, especially to treat arthritis.

e·to·do·lac
n.
 400mg tablets.

Etodolac is the generic equivalent of American Home For the American mortgage lender, see .
The American Home is a center of intercultural exchange located in Vladimir, Russia. The home is designed to model a typical American suburban home and its main focus is the ESL school that provides lessons for Russian students.
 Products' Lodine(R), an anti-inflammatory drug. There are several generic versions of this product.

Teva Pharmaceutical Industries Teva Pharmaceutical Industries Ltd. (Hebrew: טבע תעשיות פרמצבטיות בע"מ), NASDAQ: TEVA is an international pharmaceutical company headquartered in  Ltd., is Israel's largest pharmaceutical company, with three quarters of its sales outside Israel, mainly in the United States. The Company develops, manufactures and markets branded and generic human pharmaceuticals, bulk pharmaceutical chemicals, medical disposable and veterinary products.

CONTACT: Dan Suesskind

Chief Financial Officer

Teva Pharmaceutical Industries, Ltd.

(011) 972-25-892-811

or

Investor Relations Investor relations

The process by which the corporation communicates with its investors.
 Contact:

Donna N. Stein/Dan Durkin/Cindy Reid

Morgen-Walke Associates, Inc.

(212) 850-5600

or

Press Contact:

Richard Dukas/Elizabeth Pieroni

Morgen-Walke Associates, Inc.

(212) 850-5600
COPYRIGHT 1997 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1997, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Nov 26, 1997
Words:135
Previous Article:Citibank Names Jorge Bermudez Head of Global Cash Management and Trade Services.
Next Article:Gallery Resources Limited Announces Okak Bay Update Favourable Drilling At Harp Lake.
Topics:



Related Articles
Teva Pharmaceutical Industries Ltd. announces the first FDA approval of Clonazepam.
Once-daily version of Lodine granted marketing clearance by the FDA.
Faulding receives FDA approvals for atracurium besylate injection; seeks share of $57.7 million market for intravenous muscle relaxant.
Teva Receives FDA Approval Of Trazodone 150mg Tablets.
Faulding Receives FDA Approval for Acyclovir Tablets.
Faulding Inc. Receives FDA Approval for Pentoxifylline Extended-Release Tablets.
Teva Receives FDA Approval of Estazolam 1mg and 2mg Tablets.
Faulding Receives FDA Approval for Acyclovir Capsules.
Shionogi Launches New Quinolone Antibacterial "Avelox(R) Tablet 400mg" (Moxifloxacin Hydrochloride).
FDA APPROVES TEVA'S ANDA TO MARKET GENERIC VERSION OF ZOCOR.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles